Literature DB >> 9630657

Evolution of the cytochrome P450 superfamily: sequence alignments and pharmacogenetics.

D F Lewis1, E Watson, B G Lake.   

Abstract

The evolution of the cytochrome P450 (CYP) superfamily is described, with particular reference to major events in the development of biological forms during geological time. It is noted that the currently accepted timescale for the elaboration of the P450 phylogenetic tree exhibits close parallels with the evolution of terrestrial biota. Indeed, the present human P450 complement of xenobiotic-metabolizing enzymes may have originated from coevolutionary 'warfare' between plants and animals during the Devonian period about 400 million years ago. A number of key correspondences between the evolution of P450 system and the course of biological development over time, point to a mechanistic molecular biology of evolution which is consistent with a steady increase in atmospheric oxygenation beginning over 2000 million years ago, whereas dietary changes during more recent geological time may provide one possible explanation for certain species differences in metabolism. Alignment between P450 protein sequences within the same family or subfamily, together with across-family comparisons, aid the rationalization of drug metabolism specificities for different P450 isoforms, and can assist in an understanding of genetic polymorphisms in P450-mediated oxidations at the molecular level. Moreover, the variation in P450 regulatory mechanisms and inducibilities between different mammalian species are likely to have important implications for current procedures of chemical safety evaluation, which rely on pure genetic strains of laboratory bred rodents for the testing of compounds destined for human exposure. Copyright 1998 Elsevier Science B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630657     DOI: 10.1016/s1383-5742(97)00040-9

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  29 in total

Review 1.  [Pharmacogenomics. What is relevant for the internal medicine specialist?].

Authors:  P Krüth; M Wehling
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

Review 2.  Genetics of the adrenal gland.

Authors:  Constantine A Stratakis; Ioannis Bossis
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

3.  CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome.

Authors:  Vanessa S Silveira; Renata Canalle; Carlos Alberto Scrideli; Rosane G P Queiroz; Luiz Fernando Lopes; Luiz Gonzaga Tone
Journal:  Mol Cell Biochem       Date:  2012-01-04       Impact factor: 3.396

Review 4.  Pharmacological perspectives on the detoxification of plant secondary metabolites: implications for ingestive behavior of herbivores.

Authors:  Stuart McLean; Alan J Duncan
Journal:  J Chem Ecol       Date:  2006-05-23       Impact factor: 2.626

5.  Construction and application of a functional library of cytochrome P450 monooxygenases from the filamentous fungus Aspergillus oryzae.

Authors:  K H M Nazmul Hussain Nazir; Hirofumi Ichinose; Hiroyuki Wariishi
Journal:  Appl Environ Microbiol       Date:  2011-03-04       Impact factor: 4.792

6.  Evolution of the CYP2ABFGST gene cluster in rat, and a fine-scale comparison among rodent and primate species.

Authors:  Shengyong Hu; Haoyi Wang; Alyssa A Knisely; Shanti Reddy; David Kovacevic; Zhi Liu; Susan M G Hoffman
Journal:  Genetica       Date:  2007-09-18       Impact factor: 1.082

7.  Plant-Derived Small Molecule Inhibitors of Neuronal NO-Synthase: Potential Effects on Protein Degradation.

Authors:  Yoichi Osawa; Miranda Lau; Ezra R Lowe
Journal:  Plant Signal Behav       Date:  2007-03

8.  Diversification of furanocoumarin-metabolizing cytochrome P450 monooxygenases in two papilionids: Specificity and substrate encounter rate.

Authors:  Weimin Li; Mary A Schuler; May R Berenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-10       Impact factor: 11.205

9.  Role of pregnane X receptor in control of all-trans retinoic acid (ATRA) metabolism and its potential contribution to ATRA resistance.

Authors:  Ting Wang; Xiaochao Ma; Kristopher W Krausz; Jeffrey R Idle; Frank J Gonzalez
Journal:  J Pharmacol Exp Ther       Date:  2007-10-25       Impact factor: 4.030

10.  A microarray-based system for the simultaneous analysis of single nucleotide polymorphisms in human genes involved in the metabolism of anti-malarial drugs.

Authors:  Eva Maria Hodel; Serej D Ley; Weihong Qi; Frédéric Ariey; Blaise Genton; Hans-Peter Beck
Journal:  Malar J       Date:  2009-12-09       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.